NCT00066989View on ClinicalTrials.gov

Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions
Staphylococcal Infections
Interventions
DRUG

Staphylococcus aureus Immune Globulin (Human) 5%

Sponsors
All Listed Sponsors
lead

Nabi Biopharmaceuticals

INDUSTRY

NCT00066989 - Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates | Biotech Hunter | Biotech Hunter